These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5040531)

  • 21. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M; Jorgensen PB
    Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amantadine therapy in parkinsonism].
    Blomberg LH
    Lakartidningen; 1972 Nov; 69(46):5339. PubMed ID: 4650741
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles for amantadine therapy in parkinsonism].
    Gilland O
    Lakartidningen; 1972 Nov; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract]   [Full Text] [Related]  

  • 27. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
    Giuffrè R; Gambacorta D
    Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066
    [No Abstract]   [Full Text] [Related]  

  • 28. [Present-day treatment of parkinsonism in the aged].
    Siegfried J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug therapy of parkinsonism.
    Yahr MD; Duvoisin RC
    N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145
    [No Abstract]   [Full Text] [Related]  

  • 31. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 32. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 34. The comparative value of amantadine and levodopa.
    Dallos V; Heathfield K; Stone P; Allen F
    Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 36. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

  • 38. Amantadine in Parkinson's disease.
    Lancet; 1969 Aug; 2(7616):364. PubMed ID: 4183981
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M; Monaco V; Robotti CA
    Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.